Understanding of US reimbursement for NEOLA®

Important results from the project

A reimbursement strategy for the company´s product NEOLA® has been developed for the US market. Through the project, GPX Medical has gained a much stronger foundation to be able to achieve international success in the USA by laying the foundation for commercialization in the American market. In addition, the company´s competitiveness has been strengthened as the right knowledge of the payment system means that the company can focus its efforts on the activities identified in the project that need to be done in order to enter the American market more quickly.

Expected long term effects

A solid knowledge base was obtained through a survey of coverage policies for insurance players, relevant codes and code systems, payment methods, compensation and market access routes and in-depth interviews with key roles in the compensation system. Subsequently, an analysis was made in which the conclusions gave GPX Medical a very good picture of the conditions for cost reimbursement for NEOLA® and has on this basis laid out a strategy for reimbursement in the American market. The next step will be to carry out a price analysis project to set a reasonable price for NEOLA®.

Approach and implementation

The American experts have been able to use their core competence in the field of reimbursement as well as their network to be able to collect relevant information. The company has contributed with technical and medical insight into the product in order to be able to identify which keywords and tasks require understanding. Joint analyzes have made it possible to develop a final strategy for the American market in the future.